Travere Therapeutics FY25 sales surged on Filspari, but the FDA FSGS label decision was delayed to April. Click here to read ...

As January 2026 moves forward, market focus is split between three major names. The Shiba Inu coin price is holding close to ...

Starting early lets compound interest outperform timing, making time the most powerful driver of long-term wealth.

Carl Zeiss Meditec AG is rated Strong Buy with higher share price target, undervaluation & robust fundamentals. Read more on ...

The situation will probably keep getting worse unless and until our policymakers start with evidence and work from there.

Discover how to assess a company's liquidity through working capital and the cash conversion cycle. Understand key metrics ...

70% of the physicians surveyed by the RCP reported the NHS’s inability to integrate AI tools with other systems such as the ...

"The IRGC remains a potent force domestically" despite losses in the 12-day war with Israel, one Iran expert told Newsweek.

Will Gov. Dan McKee keep his job amid the Washington Bridge mess? Can the GOP win one of the offices up for grabs? Here's ...

Williams’ attempt to renege on his signed deal became a test case for the entire FBS system in the era of revenue sharing.

JOURNALIST: Just on the hate speech, The Greens and the Coalition say the bill has been rushed and aren't prepared to support it in its current form. And now members of your own party are repeatedly ...